Northern Trust’s Juno Therapeutics, Inc. JUNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-427,121
Closed -$19.5M 4313
2017
Q4
$19.5M Buy
427,121
+36,603
+9% +$1.83M ﹤0.01% 1716
2017
Q3
$17.5M Buy
390,518
+7,887
+2% +$269K ﹤0.01% 1805
2017
Q2
$11.4M Buy
382,631
+40,468
+12% +$999K ﹤0.01% 2073
2017
Q1
$7.59M Buy
342,163
+60,326
+21% +$1.29M ﹤0.01% 2309
2016
Q4
$5.31M Buy
281,837
+3,897
+1% +$95.3K ﹤0.01% 2513
2016
Q3
$8.34M Buy
277,940
+9,387
+3% +$292K ﹤0.01% 2198
2016
Q2
$10.3M Buy
268,553
+119,829
+81% +$4.97M ﹤0.01% 2005
2016
Q1
$5.67M Buy
148,724
+8,061
+6% +$281K ﹤0.01% 2332
2015
Q4
$6.18M Buy
140,663
+23,559
+20% +$1.17M ﹤0.01% 2333
2015
Q3
$4.76M Buy
117,104
+64,371
+122% +$2.82M ﹤0.01% 2470
2015
Q2
$2.81M Buy
52,733
+12,194
+30% +$647K ﹤0.01% 2876
2015
Q1
$2.46M Buy
+40,539
New +$1.97M ﹤0.01% 3003

Other funds holding JUNO

Northern Trust's JUNO Position: Q1 2018 in Review

Northern Trust sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 427,121 shares — an estimated $19.5M sold.

Northern Trust first reported a position in JUNO in Q1 2015 and held it in 12 quarters. The position peaked at $19.5M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Northern Trust reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Northern Trust sold 427,121 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $19.5M.
  • Northern Trust first reported a position in Juno Therapeutics, Inc. in Q1 2015 and held it in 12 quarters.
  • Northern Trust's Juno Therapeutics, Inc. position peaked at $19.5M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Northern Trust's 13F filing for Q1 2018, filed 9 May 2018.